-
1
-
-
0029943568
-
Plasminogen activators and matrix metalloproteinases in angiogenesis
-
Mignatti P, Rifkin DB. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enz Prot 1996; 49, 117-137.
-
(1996)
Enz Prot
, vol.49
, pp. 117-137
-
-
Mignatti, P.1
Rifkin, D.B.2
-
2
-
-
0025697078
-
Proteolytic balance and capillary morphogenesis
-
Pepper MS, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Different Dev 1990; 32, 319-328.
-
(1990)
Cell Different Dev
, vol.32
, pp. 319-328
-
-
Pepper, M.S.1
Montesano, R.2
-
3
-
-
0029097797
-
Immunolocalization of cathepsin B in human glioma - Implications for tumor invasion and angiogenesis
-
Mikkelsen T, Yan PS, Ho KL, Sameni M, Sloane BF, Rosenblum ML. Immunolocalization of cathepsin B in human glioma - implications for tumor invasion and angiogenesis. J Neurosurg 1995; 83, 285-290.
-
(1995)
J Neurosurg
, vol.83
, pp. 285-290
-
-
Mikkelsen, T.1
Yan, P.S.2
Ho, K.L.3
Sameni, M.4
Sloane, B.F.5
Rosenblum, M.L.6
-
4
-
-
0028966338
-
Cathepsin B in angiogenesis of human prostate - An immunohistochemical and immunoelectron microscopic analysis
-
Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. Cathepsin B in angiogenesis of human prostate - an immunohistochemical and immunoelectron microscopic analysis. Anat Rec 1995; 241, 353-362.
-
(1995)
Anat Rec
, vol.241
, pp. 353-362
-
-
Sinha, A.A.1
Gleason, D.F.2
Staley, N.A.3
Wilson, M.J.4
Sameni, M.5
Sloane, B.F.6
-
5
-
-
0024504371
-
In vitro angiogenesis on the human amniotic membrane: Requirements for basic fibroblast growth factor-induced proteinases
-
Mignatti P, Tsuboi R, Robbins E, Rifkin DB. In vitro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteinases. J Cell Biol 1989; 108, 671-682.
-
(1989)
J Cell Biol
, vol.108
, pp. 671-682
-
-
Mignatti, P.1
Tsuboi, R.2
Robbins, E.3
Rifkin, D.B.4
-
6
-
-
0029953671
-
Angiogenesis - A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis
-
Pepper MS, Montesano R, Mandriota SJ, Orci L, Vassalli JD. Angiogenesis - a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enz Prot 1996; 49, 138-162.
-
(1996)
Enz Prot
, vol.49
, pp. 138-162
-
-
Pepper, M.S.1
Montesano, R.2
Mandriota, S.J.3
Orci, L.4
Vassalli, J.D.5
-
9
-
-
0022499616
-
Human fibroblast collagenase: Glycosylation and tissue-specific levels of enzyme synthesis
-
Wilhelm SC, Eisen AZ, Teter M, Clark SD, Kronberger A, Goldberg G. Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci USA 1986; 83, 3756-3760.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 3756-3760
-
-
Wilhelm, S.C.1
Eisen, A.Z.2
Teter, M.3
Clark, S.D.4
Kronberger, A.5
Goldberg, G.6
-
10
-
-
0025310828
-
Human neutrophil collagenase; a distinct gene product with homology to other matrix metalloproteinases
-
Hasty KA, Pourmotabbed TF, Goldberg GI, et al. Human neutrophil collagenase; a distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990; 265, 11421-11424.
-
(1990)
J Biol Chem
, vol.265
, pp. 11421-11424
-
-
Hasty, K.A.1
Pourmotabbed, T.F.2
Goldberg, G.I.3
-
11
-
-
0028322352
-
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
-
Freije JM, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269, 16766-16773.
-
(1994)
J Biol Chem
, vol.269
, pp. 16766-16773
-
-
Freije, J.M.1
Diez-Itza, I.2
Balbin, M.3
-
12
-
-
0023919959
-
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen
-
Collier IE, Wilhelm SM, Eisen AZ, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988; 263, 6579-6587.
-
(1988)
J Biol Chem
, vol.263
, pp. 6579-6587
-
-
Collier, I.E.1
Wilhelm, S.M.2
Eisen, A.Z.3
-
13
-
-
0024330327
-
SV40-transformed human lung fibroblasts secrete a 92-kDa Type IV collagenase which is identical to that secreted by normal human macrophages
-
Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa Type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264, 17213-17221.
-
(1989)
J Biol Chem
, vol.264
, pp. 17213-17221
-
-
Wilhelm, S.M.1
Collier, I.E.2
Marmer, B.L.3
Eisen, A.Z.4
Grant, G.A.5
Goldberg, G.I.6
-
14
-
-
0019873814
-
Partial purification and characterisation of a neutral protease which cleaves type IV collagen
-
Liotta LA, Tryggvason K, Garbisa S, Robey PG, Abe S. Partial purification and characterisation of a neutral protease which cleaves type IV collagen. Biochemistry 1981; 20, 100-104.
-
(1981)
Biochemistry
, vol.20
, pp. 100-104
-
-
Liotta, L.A.1
Tryggvason, K.2
Garbisa, S.3
Robey, P.G.4
Abe, S.5
-
15
-
-
0025874373
-
Human 92- and 72-kilodalton type IV collagenases are elastases
-
Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991; 266, 7870-7875.
-
(1991)
J Biol Chem
, vol.266
, pp. 7870-7875
-
-
Senior, R.M.1
Griffin, G.L.2
Fliszar, C.J.3
Shapiro, S.D.4
Goldberg, G.I.5
Welgus, H.G.6
-
16
-
-
0029803675
-
The recognition sites of the integrins alpha1beta1 and alpha2beta1 within collagen IV are protected against gelatinase a attack in the native protein
-
Eble JA, Ries A, Lichy A, et al. The recognition sites of the integrins alpha1beta1 and alpha2beta1 within collagen IV are protected against gelatinase A attack in the native protein. J Biol Chem 1996; 271, 30964-30970.
-
(1996)
J Biol Chem
, vol.271
, pp. 30964-30970
-
-
Eble, J.A.1
Ries, A.2
Lichy, A.3
-
17
-
-
0004552673
-
Human skin fibroblast stromelysin: Structure, glycosylation, substrate specificity, and differential expression in normal and tumourigenic cells
-
Wilhelm SM, Collier IE, Kronberger A, et al. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumourigenic cells. Proc Natl Acad Sci USA 1987; 84, 6725-6729.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 6725-6729
-
-
Wilhelm, S.M.1
Collier, I.E.2
Kronberger, A.3
-
18
-
-
0023720003
-
The collagenase gene family in humans consists of at least four members
-
Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1988; 253, 187-192.
-
(1988)
Biochem J
, vol.253
, pp. 187-192
-
-
Muller, D.1
Quantin, B.2
Gesnel, M.C.3
Millon-Collard, R.4
Abecassis, J.5
Breathnach, R.6
-
19
-
-
0025641098
-
A novel metalloproteinase gene specifically expressed in stromal cell of breast carcinomas
-
Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cell of breast carcinomas. Nature 1990; 348, 699-704.
-
(1990)
Nature
, vol.348
, pp. 699-704
-
-
Basset, P.1
Bellocq, J.P.2
Wolf, C.3
-
20
-
-
0028116127
-
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3
-
Pei D, Majmudar G, Weiss SJ. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 1994; 269, 25849-25855.
-
(1994)
J Biol Chem
, vol.269
, pp. 25849-25855
-
-
Pei, D.1
Majmudar, G.2
Weiss, S.J.3
-
21
-
-
0024318368
-
Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members
-
Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 1989; 28, 5325-5334.
-
(1989)
Biochemistry
, vol.28
, pp. 5325-5334
-
-
Quantin, B.1
Murphy, G.2
Breathnach, R.3
-
22
-
-
0027515289
-
Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages
-
Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterisation of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268, 23824-23829.
-
(1993)
J Biol Chem
, vol.268
, pp. 23824-23829
-
-
Shapiro, S.D.1
Kobayashi, D.K.2
Ley, T.J.3
-
23
-
-
0030581634
-
Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein
-
Chandler S, Cossins J, Lury J, Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour-necrosis factor-α fusion protein. Biochem Biophys Res Commun 1996; 228, 421-429.
-
(1996)
Biochem Biophys Res Commun
, vol.228
, pp. 421-429
-
-
Chandler, S.1
Cossins, J.2
Lury, J.3
Wells, G.4
-
24
-
-
0028291737
-
A matrix metalloproteinase expressed on the surface of invasive tumor cells
-
Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370, 61-65.
-
(1994)
Nature
, vol.370
, pp. 61-65
-
-
Sato, H.1
Takino, T.2
Okada, Y.3
-
25
-
-
0029133344
-
cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment
-
Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995; 231, 602-608.
-
(1995)
Eur J Biochem
, vol.231
, pp. 602-608
-
-
Will, H.1
Hinzmann, B.2
-
26
-
-
0029118269
-
Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family
-
Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995; 270, 23013-23020.
-
(1995)
J Biol Chem
, vol.270
, pp. 23013-23020
-
-
Takino, T.1
Sato, H.2
Shinagawa, A.3
Seiki, M.4
-
27
-
-
0030022539
-
Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma
-
Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996; 56, 944-949.
-
(1996)
Cancer Res
, vol.56
, pp. 944-949
-
-
Puente, X.S.1
Pendas, A.M.2
Llano, E.3
Velasco, G.4
Lopez-Otin, C.5
-
28
-
-
0028907318
-
Mechanism of cell surface activation of 72 kDa type IV collagenase
-
Strongin A, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 1995; 270, 5331-5338.
-
(1995)
J Biol Chem
, vol.270
, pp. 5331-5338
-
-
Strongin, A.1
Collier, I.2
Bannikov, G.3
Marmer, B.L.4
Grant, G.A.5
Goldberg, G.I.6
-
29
-
-
0031025218
-
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
-
Ohuchi E, Imai K, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272, 2446-2451.
-
(1997)
J Biol Chem
, vol.272
, pp. 2446-2451
-
-
Ohuchi, E.1
Imai, K.2
Sato, H.3
Seiki, M.4
Okada, Y.5
-
30
-
-
0030581637
-
Identification of MMP-18, a putative novel human matrix metalloproteinase
-
Cossins J, Dudgeon TJ, Catlin G, Gearing AJH, Clements JM. Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 1996; 228, 494-498.
-
(1996)
Biochem Biophys Res Commun
, vol.228
, pp. 494-498
-
-
Cossins, J.1
Dudgeon, T.J.2
Catlin, G.3
Gearing, A.J.H.4
Clements, J.M.5
-
31
-
-
0028485654
-
Processing of tumor necrosis factor-a precursor by metalloproteinases
-
Gearing AJH, Beckett P, Christodoulou M, et al. Processing of tumor necrosis factor-a precursor by metalloproteinases. Nature 1994; 370, 555-557.
-
(1994)
Nature
, vol.370
, pp. 555-557
-
-
Gearing, A.J.H.1
Beckett, P.2
Christodoulou, M.3
-
32
-
-
8044257704
-
A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
-
Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385, 729-733.
-
(1997)
Nature
, vol.385
, pp. 729-733
-
-
Black, R.A.1
Rauch, C.T.2
Kozlosky, C.J.3
-
33
-
-
8044250278
-
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha
-
Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385, 733-736.
-
(1997)
Nature
, vol.385
, pp. 733-736
-
-
Moss, M.L.1
Jin, S.L.2
Milla, M.E.3
-
34
-
-
0027683226
-
Structural biochemistry and activation of matrix metalloproteinases
-
Kleiner DE, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 1993; 5, 891-897.
-
(1993)
Curr Opin Cell Biol
, vol.5
, pp. 891-897
-
-
Kleiner, D.E.1
Stetler-Stevenson, W.G.2
-
35
-
-
0029014101
-
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
-
Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995; 375, 244-247.
-
(1995)
Nature
, vol.375
, pp. 244-247
-
-
Pei, D.1
Weiss, S.J.2
-
36
-
-
0029885707
-
Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity
-
Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity. J Biol Chem 1996; 271, 9135-9140.
-
(1996)
J Biol Chem
, vol.271
, pp. 9135-9140
-
-
Pei, D.1
Weiss, S.J.2
-
37
-
-
0022382006
-
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
-
Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985; 318, 66-69.
-
(1985)
Nature
, vol.318
, pp. 66-69
-
-
Docherty, A.J.P.1
Lyons, A.2
Smith, B.J.3
Wright, E.M.4
Stephens, P.E.5
Harris, T.J.R.6
-
38
-
-
0024394212
-
Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family
-
Stetler-Stevenson WG, Krutzsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 1989; 264, 17374-17378.
-
(1989)
J Biol Chem
, vol.264
, pp. 17374-17378
-
-
Stetler-Stevenson, W.G.1
Krutzsch, H.C.2
Liotta, L.A.3
-
39
-
-
0028125576
-
Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and the mapping of the TIMP-3 gene to chromosome 22
-
Apte SS, Mattei MG, Olsen BR. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and the mapping of the TIMP-3 gene to chromosome 22. Genomics 1994; 19, 86-90.
-
(1994)
Genomics
, vol.19
, pp. 86-90
-
-
Apte, S.S.1
Mattei, M.G.2
Olsen, B.R.3
-
40
-
-
0029806813
-
Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase 4
-
Greene J, Wang MS, Liu YLE, Raymond LA, Rosen C, Shi YNE. Molecular cloning and characterisation of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996; 271, 30375-30380.
-
(1996)
J Biol Chem
, vol.271
, pp. 30375-30380
-
-
Greene, J.1
Wang, M.S.2
Liu, Y.L.E.3
Raymond, L.A.4
Rosen, C.5
Shi, Y.N.E.6
-
41
-
-
0028237165
-
Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion
-
Galis ZS, Muszynski M, Sukhova G, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75, 181-189.
-
(1994)
Circ Res
, vol.75
, pp. 181-189
-
-
Galis, Z.S.1
Muszynski, M.2
Sukhova, G.3
-
42
-
-
0001330615
-
The organization of ground substance and basement membrane and its significance in tissue injury, disease and growth
-
Gersh I, Catchpole HR. The organization of ground substance and basement membrane and its significance in tissue injury, disease and growth. Am J Anat 1949; 85, 457-507.
-
(1949)
Am J Anat
, vol.85
, pp. 457-507
-
-
Gersh, I.1
Catchpole, H.R.2
-
43
-
-
0029946569
-
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
-
Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996; 149, 273-282.
-
(1996)
Am J Pathol
, vol.149
, pp. 273-282
-
-
Heppner, K.J.1
Matrisian, L.M.2
Jensen, R.A.3
Rodgers, W.H.4
-
44
-
-
0028085533
-
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior
-
Basset P, Wolf C, Rouyer N, Bellocq JP, Rio MC, Chambon P. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 1994; 74, 1045-1049.
-
(1994)
Cancer
, vol.74
, pp. 1045-1049
-
-
Basset, P.1
Wolf, C.2
Rouyer, N.3
Bellocq, J.P.4
Rio, M.C.5
Chambon, P.6
-
45
-
-
0025837651
-
Detection of mRNAs encoding collagenase 1 and stromelysin 2 in carcinomas of the head and neck by in situ hybridization
-
Polette M, Clavel C, Muller D, Abecassis J, Binninger I, Birembaut P. Detection of mRNAs encoding collagenase 1 and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 1991; 11, 76-83.
-
(1991)
Invasion Metastasis
, vol.11
, pp. 76-83
-
-
Polette, M.1
Clavel, C.2
Muller, D.3
Abecassis, J.4
Binninger, I.5
Birembaut, P.6
-
46
-
-
0029806982
-
Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridisation and immunoelectron microscopy
-
Ohtani H, Motohashi H, Sato H, Seiki M, Nagura H. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridisation and immunoelectron microscopy. Int J Cancer 1996; 68, 565-570.
-
(1996)
Int J Cancer
, vol.68
, pp. 565-570
-
-
Ohtani, H.1
Motohashi, H.2
Sato, H.3
Seiki, M.4
Nagura, H.5
-
47
-
-
0029129995
-
Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
-
Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 1995; 72, 575-582.
-
(1995)
Br J Cancer
, vol.72
, pp. 575-582
-
-
Zeng, Z.S.1
Guillem, J.G.2
-
48
-
-
0029058729
-
The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer
-
Gallegos NC, Smales C, Savage FG, Hembry RM, Boulos PB. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995; 4, 21-29.
-
(1995)
Surg Oncol
, vol.4
, pp. 21-29
-
-
Gallegos, N.C.1
Smales, C.2
Savage, F.G.3
Hembry, R.M.4
Boulos, P.B.5
-
49
-
-
0031057805
-
Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer - A novel approach from immune/ inflammatory aspect
-
Takeha S, Fujiyama Y, Bamba T, Sorsa T, Nagura H, Ohtani H. Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer - a novel approach from immune/ inflammatory aspect. Jpn J Cancer Res 1997; 88, 72-81.
-
(1997)
Jpn J Cancer Res
, vol.88
, pp. 72-81
-
-
Takeha, S.1
Fujiyama, Y.2
Bamba, T.3
Sorsa, T.4
Nagura, H.5
Ohtani, H.6
-
50
-
-
0030016640
-
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma
-
Seir CFM, Kubben FJGM, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996; 74, 413-417.
-
(1996)
Br J Cancer
, vol.74
, pp. 413-417
-
-
Seir, C.F.M.1
Kubben, F.J.G.M.2
Ganesh, S.3
-
51
-
-
0030467609
-
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma
-
Chenard M-P, O'Siorain L, Shering S, et al. High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma. Int J Cancer 1996; 69, 448-451.
-
(1996)
Int J Cancer
, vol.69
, pp. 448-451
-
-
Chenard, M.-P.1
O'Siorain, L.2
Shering, S.3
-
52
-
-
0029952713
-
Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
-
Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996; 2, 461-462.
-
(1996)
Nat Med
, vol.2
, pp. 461-462
-
-
Murray, G.I.1
Duncan, M.E.2
O'Neil, P.3
Melvin, W.T.4
Fothergill, J.E.5
-
53
-
-
0009708546
-
Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9
-
Zeng ZS, Huang Y, Cohen AM, Guillem JG. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14, 3133-3140.
-
(1996)
J Clin Oncol
, vol.14
, pp. 3133-3140
-
-
Zeng, Z.S.1
Huang, Y.2
Cohen, A.M.3
Guillem, J.G.4
-
54
-
-
0029737908
-
TIMP1 and adverse prognosis in non-small cell lung cancer
-
Fong KM, Kida Y, Zimmerman PV, Smith PJ. TIMP1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res 1996; 2, 1369-1372.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1369-1372
-
-
Fong, K.M.1
Kida, Y.2
Zimmerman, P.V.3
Smith, P.J.4
-
55
-
-
0029965059
-
High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer
-
Grignon DJ, Sakr W, Ravery V, et al. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer. Cancer Res 1996; 56, 1654-1659.
-
(1996)
Cancer Res
, vol.56
, pp. 1654-1659
-
-
Grignon, D.J.1
Sakr, W.2
Ravery, V.3
-
56
-
-
0028275891
-
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
-
Johnson MD, Kim HR, Chesler L, Tsao-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 1994; 160, 194-202.
-
(1994)
J Cell Physiol
, vol.160
, pp. 194-202
-
-
Johnson, M.D.1
Kim, H.R.2
Chesler, L.3
Tsao-Wu, G.4
Bouck, N.5
Polverini, P.J.6
-
57
-
-
0023696675
-
Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells
-
Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 1988; 48, 5539-5545.
-
(1988)
Cancer Res
, vol.48
, pp. 5539-5545
-
-
Schultz, R.M.1
Silberman, S.2
Persky, B.3
Bajkowski, A.S.4
Carmichael, D.F.5
-
58
-
-
0025778347
-
Tumour cell invasion inhibited by TIMP-2
-
Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG. Tumour cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991; 83, 775-779.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 775-779
-
-
Albini, A.1
Melchiori, A.2
Santi, L.3
Liotta, L.A.4
Brown, P.D.5
Stetler-Stevenson, W.G.6
-
59
-
-
0025893605
-
Inhibition of tumour invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
-
DeClerck YA, Yean T-D, Chan D, Shimada H, Langley KE. Inhibition of tumour invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res 1991; 51, 2151-2157.
-
(1991)
Cancer Res
, vol.51
, pp. 2151-2157
-
-
DeClerck, Y.A.1
Yean, T.-D.2
Chan, D.3
Shimada, H.4
Langley, K.E.5
-
60
-
-
0026573378
-
Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases
-
DeClerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992; 52, 701-708.
-
(1992)
Cancer Res
, vol.52
, pp. 701-708
-
-
DeClerck, Y.A.1
Perez, N.2
Shimada, H.3
Boone, T.C.4
Langley, K.E.5
Taylor, S.M.6
-
61
-
-
0027383944
-
Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation
-
Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993; 157, 351-358.
-
(1993)
J Cell Physiol
, vol.157
, pp. 351-358
-
-
Murphy, A.N.1
Unsworth, E.J.2
Stetler-Stevenson, W.G.3
-
62
-
-
0025351278
-
Identification of an inhibitor of neovascularization from cartilage
-
Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990; 248, 1408-1410.
-
(1990)
Science
, vol.248
, pp. 1408-1410
-
-
Moses, M.A.1
Sudhalter, J.2
Langer, R.3
-
63
-
-
0002023426
-
Recent advances in matrix metalloproteinase inhibitor research
-
Beckett RP, Davidson AH, Drummond AH, Huxley P, Whittaker M. Recent advances in matrix metalloproteinase inhibitor research. Drug Dev Today 1996; 1, 16-26.
-
(1996)
Drug Dev Today
, vol.1
, pp. 16-26
-
-
Beckett, R.P.1
Davidson, A.H.2
Drummond, A.H.3
Huxley, P.4
Whittaker, M.5
-
64
-
-
0029586589
-
Matrix metalloproteinase inhibition: A review of anti-tumour activity
-
Brown PD, Giavazzi R. Matrix metalloproteinase inhibition: a review of anti-tumour activity. Ann Oncol 1995; 6, 967-974.
-
(1995)
Ann Oncol
, vol.6
, pp. 967-974
-
-
Brown, P.D.1
Giavazzi, R.2
-
65
-
-
0028838862
-
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor
-
Grams F, Crimmin M, Hinnes L, et al. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry 1995; 34, 14012-14020.
-
(1995)
Biochemistry
, vol.34
, pp. 14012-14020
-
-
Grams, F.1
Crimmin, M.2
Hinnes, L.3
-
66
-
-
0027996297
-
Potent and selective inhibitors of gelatinase A. 2. Carboxylic acids and phosphonic acid derivatives
-
Morphy JR, Beeley NRA, Boyce BA. Potent and selective inhibitors of gelatinase A. 2. Carboxylic acids and phosphonic acid derivatives. Bioorg Med Chem Lett 1994; 4, 2747-2752.
-
(1994)
Bioorg Med Chem Lett
, vol.4
, pp. 2747-2752
-
-
Morphy, J.R.1
Beeley, N.R.A.2
Boyce, B.A.3
-
67
-
-
0030475119
-
Recent advances in the field of matrix metalloproteinase inhibitors (patent update)
-
Beckett RP. Recent advances in the field of matrix metalloproteinase inhibitors (patent update). Exp Opin Ther Patents 1996; 6, 1305-1315.
-
(1996)
Exp Opin Ther Patents
, vol.6
, pp. 1305-1315
-
-
Beckett, R.P.1
-
68
-
-
0023245356
-
A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity
-
Golub LM, McNamara TF, D'Angelo G, Greenwald RA, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dental Res 1987; 66, 1310-1314.
-
(1987)
J Dental Res
, vol.66
, pp. 1310-1314
-
-
Golub, L.M.1
McNamara, T.F.2
D'Angelo, G.3
Greenwald, R.A.4
Ramamurthy, N.S.5
-
69
-
-
0027519832
-
Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl) -seryl-L-valine]
-
Naito K, Nakajima S, Kanbayashi N, Okuyama A, Goto M. Inhibition of metalloproteinase activity of rheumatoid arthritis synovial cells by a new inhibitor [BE16627B; L-N-(N-hydroxy-2-isobutylsuccinamoyl) -seryl-L-valine]. Agents Actions 1993; 39, 182-186.
-
(1993)
Agents Actions
, vol.39
, pp. 182-186
-
-
Naito, K.1
Nakajima, S.2
Kanbayashi, N.3
Okuyama, A.4
Goto, M.5
-
70
-
-
0028856897
-
Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins
-
Tamaki K, Tanzawa K, Kurihara S, et al. Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins. Chem Pharmac Bull 1995; 43, 1883-1893.
-
(1995)
Chem Pharmac Bull
, vol.43
, pp. 1883-1893
-
-
Tamaki, K.1
Tanzawa, K.2
Kurihara, S.3
-
71
-
-
0023919232
-
Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells
-
Reich R, Thompson EW, Iwamoto Y, et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 1988; 48, 3307-3312.
-
(1988)
Cancer Res
, vol.48
, pp. 3307-3312
-
-
Reich, R.1
Thompson, E.W.2
Iwamoto, Y.3
-
72
-
-
0029934985
-
Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94)
-
Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Control of lymphatic and hematogenous metastases of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 1996; 56, 2815-2822.
-
(1996)
Cancer Res
, vol.56
, pp. 2815-2822
-
-
Eccles, S.A.1
Box, G.M.2
Court, W.J.3
Bone, E.A.4
Thomas, W.5
Brown, P.D.6
-
73
-
-
0028889359
-
Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice
-
Sledge GW, Qulali M, Goulet R, Bone EA, Fife R. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Res 1995; 87, 1546-1550.
-
(1995)
J Natl Cancer Res
, vol.87
, pp. 1546-1550
-
-
Sledge, G.W.1
Qulali, M.2
Goulet, R.3
Bone, E.A.4
Fife, R.5
-
74
-
-
2042469417
-
The role of collagenases in Tumour Invasion
-
Tarin D (ed.), New York: Academic Press
-
Strauch L. The role of collagenases in Tumour Invasion. In: Tarin D (ed.), Tissue Interactions in Carcinogenesis. New York: Academic Press 1972: 399-434.
-
(1972)
Tissue Interactions in Carcinogenesis
, pp. 399-434
-
-
Strauch, L.1
-
75
-
-
0029165411
-
Inhibition of organ invasion by metalloproteinase inhibitor, BB-94 (batimastat) in two human colon metastasis models
-
Watson SA, Morris TM, Robinson G, Crimmin M, Brown PD, Hardcastle JD. Inhibition of organ invasion by metalloproteinase inhibitor, BB-94 (batimastat) in two human colon metastasis models. Cancer Res 1995; 55, 3629-3633.
-
(1995)
Cancer Res
, vol.55
, pp. 3629-3633
-
-
Watson, S.A.1
Morris, T.M.2
Robinson, G.3
Crimmin, M.4
Brown, P.D.5
Hardcastle, J.D.6
-
76
-
-
9044235773
-
Effect of matrix metalloproteinase inhibitors on tumour growth and spontaneous metastasis
-
Conway JG, Trexler SJ, Wakefield JA, et al. Effect of matrix metalloproteinase inhibitors on tumour growth and spontaneous metastasis. Clin Exp Metastasis 1996; 14, 115-124.
-
(1996)
Clin Exp Metastasis
, vol.14
, pp. 115-124
-
-
Conway, J.G.1
Trexler, S.J.2
Wakefield, J.A.3
-
77
-
-
0028470454
-
Barriers to drug delivery in solid tumours
-
Jain RK. Barriers to drug delivery in solid tumours. Sci Am 1994; 271, 58-65.
-
(1994)
Sci Am
, vol.271
, pp. 58-65
-
-
Jain, R.K.1
-
78
-
-
0030500450
-
New perspectives in clinical oncology from angiogenesis research
-
Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer 1996; 32A, 2535-2539.
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 2535-2539
-
-
Folkman, J.1
-
79
-
-
0002635973
-
An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer
-
Parsons SL, Watson SA, Griffin NR, Steele RJC. An open phase I/II study of the oral matrix metalloproteinase inhibitor marimastat in patients with inoperable gastric cancer. Ann Oncol 1996; 7, 47.
-
(1996)
Ann Oncol
, vol.7
, pp. 47
-
-
Parsons, S.L.1
Watson, S.A.2
Griffin, N.R.3
Steele, R.J.C.4
-
80
-
-
8244260609
-
Conversion of a highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor
-
An Z, Wang X, Willmott N, et al. Conversion of a highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis 1997; 15, 184-195.
-
(1997)
Clin Exp Metastasis
, vol.15
, pp. 184-195
-
-
An, Z.1
Wang, X.2
Willmott, N.3
-
81
-
-
0028939303
-
Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
-
Taraboletti G, Garofalo A, Belotti D, et al. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 1995; 87, 293-298.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 293-298
-
-
Taraboletti, G.1
Garofalo, A.2
Belotti, D.3
-
82
-
-
0028625431
-
Low molecular weight inhibitors in corneal ulceration
-
Galardy RE, Cassabone ME, Giese C, et al. Low molecular weight inhibitors in corneal ulceration. Ann NY Acad Sci 1994; 732, 315-323.
-
(1994)
Ann NY Acad Sci
, vol.732
, pp. 315-323
-
-
Galardy, R.E.1
Cassabone, M.E.2
Giese, C.3
-
83
-
-
0027956746
-
Inhibition of angiogenesis by the matrix metalloproteinase inhibitor N-[2.R-2-(hydroxyamido-carbonymethyl)-4-methylpentanoyl]-L-tryptophan methylamide
-
Galardy RE, Grobelny D, Foellmer HG, Fernandez LA. Inhibition of angiogenesis by the matrix metalloproteinase inhibitor N-[2.R-2-(hydroxyamido-carbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res 1994; 54, 4715-4718.
-
(1994)
Cancer Res
, vol.54
, pp. 4715-4718
-
-
Galardy, R.E.1
Grobelny, D.2
Foellmer, H.G.3
Fernandez, L.A.4
-
84
-
-
0030042145
-
Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma
-
Anderson IC, Shipp MA, Docherty AJP, Teicher BA. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 1996; 56, 715-710.
-
(1996)
Cancer Res
, vol.56
, pp. 715-1710
-
-
Anderson, I.C.1
Shipp, M.A.2
Docherty, A.J.P.3
Teicher, B.A.4
-
85
-
-
0343900695
-
A phase I clinical trial of the matrix metalloproteinase inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer
-
in press
-
Thomas H, Adams M. A phase I clinical trial of the matrix metalloproteinase inhibitor, marimastat, administered concurrently with carboplatin to patients with relapsed ovarian cancer (abstr). Eur J Cancer 1997; in press.
-
(1997)
Eur J Cancer
-
-
Thomas, H.1
Adams, M.2
-
86
-
-
0002244576
-
Phase I study of matrix metalloproteinase (MMP) inhibitor batimastat (BB-94) in patients with malignant pleural effusions
-
Macaulay VM, O'Byrne KJ, Saunders MP, et al. Phase I study of matrix metalloproteinase (MMP) inhibitor batimastat (BB-94) in patients with malignant pleural effusions. Br J Cancer 1995; 71, 11.
-
(1995)
Br J Cancer
, vol.71
, pp. 11
-
-
Macaulay, V.M.1
O'Byrne, K.J.2
Saunders, M.P.3
-
87
-
-
0002338012
-
The tolerability and pharmacokinetics of the cartilage protective agent (RO32-3555) in healthy male volunteers
-
Wood ND, Aitken M, Harris S, Kitchener S, Mcclelland GR, Sharp S. The tolerability and pharmacokinetics of the cartilage protective agent (RO32-3555) in healthy male volunteers. Br J Clin Pharm 1996; 42, 676-677.
-
(1996)
Br J Clin Pharm
, vol.42
, pp. 676-677
-
-
Wood, N.D.1
Aitken, M.2
Harris, S.3
Kitchener, S.4
Mcclelland, G.R.5
Sharp, S.6
-
88
-
-
0345661206
-
Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers
-
in press
-
Millar AW, Brown PD, Moore J, et al. Results of single and repeat dose studies of the oral matrix metalloproteinase inhibitor marimastat in healthy male volunteers. Br J Clin Pharm 1997; in press.
-
(1997)
Br J Clin Pharm
-
-
Millar, A.W.1
Brown, P.D.2
Moore, J.3
-
89
-
-
0001015980
-
A phase I study of the matrix metalloproteinase (MMP) inhibitor AG3340 given in single doses to healthy volunteers
-
Collier MA, Yuen GJ, Bansal SK, et al. A phase I study of the matrix metalloproteinase (MMP) inhibitor AG3340 given in single doses to healthy volunteers. Proc Am Ass Cancer Res 1997; 38, 221.
-
(1997)
Proc Am Ass Cancer Res
, vol.38
, pp. 221
-
-
Collier, M.A.1
Yuen, G.J.2
Bansal, S.K.3
-
90
-
-
0024518775
-
CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer
-
Rubin SC, Hoskins WJ, Hakes TB. CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer. Am J Obstet Gynecol 1989; 160, 667-671.
-
(1989)
Am J Obstet Gynecol
, vol.160
, pp. 667-671
-
-
Rubin, S.C.1
Hoskins, W.J.2
Hakes, T.B.3
-
91
-
-
0019835719
-
CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer
-
Goldenberg DM, Neville A, Carter A. CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. J Cancer Res Clin Oncol 1981; 101, 239-242.
-
(1981)
J Cancer Res Clin Oncol
, vol.101
, pp. 239-242
-
-
Goldenberg, D.M.1
Neville, A.2
Carter, A.3
-
92
-
-
0024599612
-
Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II radical prostatectomy treated patients
-
Stamey TA, Kabalin JW, McNeal JE. Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate II radical prostatectomy treated patients. J Urol 1989; 141, 1076-1083.
-
(1989)
J Urol
, vol.141
, pp. 1076-1083
-
-
Stamey, T.A.1
Kabalin, J.W.2
McNeal, J.E.3
-
93
-
-
0022625713
-
Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas
-
Steinberg W, Gelfand R, Anderson K. Comparison of the sensitivity and specificity of the CA 19-9 and CEA assays in detecting cancer of the pancreas. Gastroenterology 1986; 90, 343-349.
-
(1986)
Gastroenterology
, vol.90
, pp. 343-349
-
-
Steinberg, W.1
Gelfand, R.2
Anderson, K.3
-
94
-
-
0001176281
-
A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced colorectal cancer
-
Primrose J, Bleiberg H, Daniel F, et al. A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced colorectal cancer. Ann Oncol 1996; 7, 35.
-
(1996)
Ann Oncol
, vol.7
, pp. 35
-
-
Primrose, J.1
Bleiberg, H.2
Daniel, F.3
-
95
-
-
0002750508
-
A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer
-
Poole C, Adams M, Barley V, et al. A dose-finding study of marimastat, an oral matrix metalloproteinase inhibitor, in patients with advanced ovarian cancer. Ann Oncol 1996; 7, 68.
-
(1996)
Ann Oncol
, vol.7
, pp. 68
-
-
Poole, C.1
Adams, M.2
Barley, V.3
-
96
-
-
0000003860
-
360 patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor
-
Millar A, Brown P. 360 patient meta-analysis of studies of marimastat, a novel matrix metalloproteinase inhibitor. Ann Oncol 1996; 7, 123.
-
(1996)
Ann Oncol
, vol.7
, pp. 123
-
-
Millar, A.1
Brown, P.2
-
97
-
-
0026442957
-
Gelatinase in cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders
-
Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 1992; 41, 29-34.
-
(1992)
J Neuroimmunol
, vol.41
, pp. 29-34
-
-
Gijbels, K.1
Masure, S.2
Carton, H.3
Opdenakker, G.4
-
98
-
-
0028825270
-
Matrix metalloproteinases in brain injury
-
Rosenberg GA. Matrix metalloproteinases in brain injury. J Neurotrauma 1995; 12, 833-842.
-
(1995)
J Neurotrauma
, vol.12
, pp. 833-842
-
-
Rosenberg, G.A.1
|